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The unfolded protein response is required to maintain
the integrity of the endoplasmic reticulum, prevent
oxidative stress and preserve differentiation in β-cells
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Diabetes is an epidemic of worldwide proportions caused by β-cell failure. Nutrient fluctuations and insulin resistance drive β-cells to synthesize
insulin beyond their capacity for protein folding and secretion and thereby activate the unfolded protein response (UPR), an adaptive signalling
pathway to promote cell survival upon accumulation of unfolded protein in the endoplasmic reticulum (ER). Protein kinase-like endoplasmic
reticulum kinase (PERK) signals one component of the UPR through phosphorylation of eukaryotic initiation factor 2 on the α-subunit (eIF2α)
to attenuate protein synthesis, thereby reducing the biosynthetic burden. β-Cells uniquely require PERK-mediated phosphorylation of eIF2α to
preserve cell function. Unabated protein synthesis in β-cells is sufficient to initiate a cascade of events, including oxidative stress, that are char-
acteristic of β-cell failure observed in type 2 diabetes. In contrast to acute adaptive UPR activation, chronic activation increases expression of the
proapoptotic transcription factor CAAT/enhancer-binding protein homologous protein (CHOP). Chop deletion in insulin-resistant mice profoundly
increases β-cell mass and prevents β-cell failure to forestall the progression of diabetes. The findings suggest an unprecedented link by which
protein synthesis and/or misfolding in the ER causes oxidative stress and should encourage the development of novel strategies to treat diabetes.
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Introduction
Type 2 diabetes is an epidemic in which tissues, such as
muscle, fat and liver, become resistant to insulin and the pan-
creas fails to compensate adequately [1]. Insulin deficiency or
resistance causes hyperglycaemia and hyperlipidaemia charac-
teristic of the diabetic state. Unfortunately, little is known
about how the β-cell responds to elevated blood glucose
to increase insulin transcription, translation and secretion.
When the β-cell compensates for insulin resistance, it must
restructure the secretory apparatus to support high-level insulin
production. Recent studies suggest that the ability of β-cells
to compensate for hyperglycaemia-driven increases in insulin
production requires an intracellular signalling pathway, the
unfolded protein response (UPR) that emanates from the
endoplasmic reticulum (ER).
The Endoplasmic Reticulum: Protein
Folding, Quality Control and ERAD
The ER is the site where proteins destined for the cell surface and
endomembrane system enter the secretory pathway. Approx-
imately one third of all proteins translocate across the ER
membrane, where they fold into their proper three-dimensional
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structures and are subject to glycosylation, hydroxylation, lipi-
dation and disulphide bond formation [2–4]. The ER contains
an extremely high Ca2+ concentration and is occupied by
chaperone proteins, catalysts of protein folding and enzymatic
machinery for post-translational modifications [5]. Only prop-
erly folded proteins exit the ER to the Golgi compartment for
further processing before trafficking to their final destina-
tion. The mechanisms for this exquisitely sensitive and specific
quality control are under active investigation, but are not yet
well defined. Retention of unfolded proteins in the ER lumen
occurs through interaction with ER-resident peptide-binding
proteins, such as BiP (immunoglobulin heavy chain-binding
protein) and GRP94 (glucose-regulated protein). ER-associated
protein degradation (ERAD) is the process whereby misfolded
proteins are recognized in the ER, targeted to a channel within
the ER membrane, extracted from the ER membrane and
delivered to the proteasome [6]. At a minimum, quality con-
trol is mediated through the processing of N-linked glycans
that are primarily recognized by lectin-binding proteins in the
ER lumen [7]. These lectins direct refolding (e.g. CNX, CRT),
anterograde transport (e.g. LMAN1) or ERAD (e.g. EDEMs,
OS-9, XPT3-B) [8,9].
Protein misfolding occurs in the ER as a consequence of
a number of insults, including pharmacological perturbation,
alterations in calcium, redox status or nutrient availability,
mutations in ER chaperones or their client proteins, viral
infection, as well as differentiation of cells that secrete large
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amounts of proteins. The accumulation of unfolded proteins
in the ER lumen activates the UPR [5,10]. The UPR is an adap-
tive response designed to resolve the protein-folding defect by
(i) reducing protein influx into the ER; (ii) increasing the capac-
ity to promote productive protein folding and (iii) increasing
the clearance of misfolded proteins in the ER lumen through
ERAD and autophagy (figure 1). These strategies may exhibit
temporally separate phases of the UPR. Reduced influx occurs
rapidly and transiently, and prevents further generation of
misfolded proteins, while upregulation of protein maturation
and degradation machinery occurs after UPR-dependent gene
induction. Over time, homeostasis may be re-established in the
ER to resolve the protein-folding defect [11]. If homeostasis
is not restored, the UPR is chronically activated and leads to
apoptosis. The mechanisms that decipher the protein folding
status and orchestrate a coordinated downstream response,
either adaptation or apoptosis, are fundamentally significant,
unknown, and require further investigation.
UPR Translational and Transcriptional
Control
The UPR is signalled through activation of the protein kinases




























Figure 1. Pathways of protein misfolding that lead to cell death. Nascent
unfolded polypeptides enter the endoplasmic reticulum (ER) and interact
with chaperones and catalysts of protein folding to mature into compact,
thermodynamically favourable structures. Failure of this process results in
persistence of misfolded polypeptide–chaperone complexes or extraction
of soluble, misfolded protein from the ER and through ER-associated
protein degradation (ERAD). The formation of insoluble protein aggregates
requires clearance by autophagy. ER stress stimuli impair polypeptide
folding and induce adaptive increases in chaperones and catalysts within
the ER lumen through unfolded protein response (UPR) sensor activation.
Chronic or overwhelming stimuli elicit a number of apoptotic signals
including oxidative stress, cJun-N-terminal kinase (JNK) activation,
CHOP expression, cleavage of caspase 12 and activation of the intrinsic
mitochondrial-dependent cell death pathway. Physiological stimuli that can
activate the UPR in the β-cell include expression of misfolded proinsulin or
islet amyloid polypeptide (IAPP), oxidative stress [reactive oxygen species

































Figure 2. Signalling the unfolded protein response (UPR). The UPR
sensors protein kinase-like endoplasmic reticulum kinase (PERK), inositol-
requiring enzyme 1 (IRE1) and ATF6 control mRNA translation and
transcriptional induction of UPR-regulated genes. Interaction of BiP
with each UPR sensor prevents UPR signalling. Upon accumulation
of unfolded protein, BiP is released from each sensor, leading to its
activation. The ER protein kinase PERK is activated by homodimerization
and autophosphorylation to phosphorylate eukaryotic initiation factor 2
α-subunit (eIF2α), thereby reducing the rate of mRNA translation and
the biosynthetic protein-folding load on the ER. eIF2α phosphorylation
paradoxically increases translation of Atf4 mRNA to produce a transcription
factor that activates expression of genes encoding protein chaperones,
ER-associated protein degradation (ERAD) machinery, enzymes that
reduce oxidative stress and functions in amino acid biosynthesis and
transport. Dimerization of the ER protein kinase IRE1 triggers its
endoribonuclease activity to induce cleavage of Xbp1 mRNA. Xbp1 mRNA
is then ligated by an uncharacterized RNA ligase and translated to produce
XBP1s. Concurrently, ATF6 released from BiP transits to the Golgi where
it is cleaved to release a transcriptionally active fragment. Cleaved ATF6
acts in concert with XBP1s to induce expression of genes encoding protein
chaperones and ERAD machinery. The RNase activity of IRE1 also degrades
selective cellular mRNAs to reduce the client protein load upon the ER.
endoplasmic reticulum kinase (PERK) and cleavage of the
transcription factor ATF6 (figure 2) [11,12]. The three UPR
sensors are maintained in an inactive state through interac-
tion with the protein chaperone BiP. It is proposed that as
unfolded proteins accumulate, bind and sequester BiP, they
promote BiP dissociation from PERK, IRE1 and ATF6 [13,14].
BiP release from IRE1 and PERK permits their homodimer-
ization, trans-autophosphorylation and activation. Activated
PERK phosphorylates the α-subunit of the translation initia-
tion factor 2 (eIF2α) leading to rapid and transient inhibition
of protein synthesis [15]. eIF2 is a heterotrimeric GTPase
required to bring initiator methionyl tRNA to the ribosome
for AUG initiation codon selection [16]. Phosphorylation of
eIF2α inhibits the GDP/GTP exchange reaction on eIF2,
thereby preventing eIF2 recycling and the initial step of
polypeptide synthesis [15,17,18]. Paradoxically, eIF2α phos-
phorylation is required for the translation of several mRNAs
(Gadd34, Atf5, Cat1), including the bZiP transcription fac-
tor ATF4 [19]. This mechanism apparently involves ribosomes
scanning through upstream open reading frames in the 5′ end
of the mRNA because of limiting amounts of GTP-bound
eIF2-tRNAmet.
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Although there are α- and β-alleles of both IRE1 and ATF6
in the mammalian genome, only IRE1α is expressed in all
tissues and only ATF6α signals the UPR. IRE1β is selectively
expressed in intestinal epithelial cells and it is not known
what genes are regulated by ATF6β. IRE1 activation elicits
an endoribonuclease function that induces non-conventional
splicing of Xbp1 mRNA. Splicing of Xbp1 mRNA, the only
known splicing substrate of IRE1, removes a 26-base intron
that alters the translation reading frame to produce a highly
active bZiP transcription factor that activates genes encoding
ER protein chaperones, lipid biosynthetic enzymes and ERAD
functions [20–22]. Upon release from BiP, ATF6 traffics to the
Golgi complex where it is cleaved by the S1P and S2P processing
enzymes to produce a cytosolic fragment that activates tran-
scription of genes providing complementary and overlapping
functions with those activated by XBP1 which restores produc-
tive ER protein folding and increases ERAD [23–25]. Indeed,
cells deleted in either Ire1α, Xbp1 or Atf6α are defective in ERAD
[21,25–27].
Signals Downstream of eIF2α
Phosphorylation – Regulation
of Transcription by ATF4 and CHOP
During periods of ER stress, the selective translation of Atf4
mRNA produces a factor that binds to the amino acid
response element (AARE) in target genes [28,29], such as
Atf3, Chop/Gadd153 and Gadd34/MyD116/Ppp1r15a [30,31].
Recent studies, as well as our own, indicate chronic UPR
activation causes induction of CHOP that is essential for
the apoptotic response to chronic protein misfolding in the
ER [32–34]. CHOP was originally isolated as a gene induced
in response to DNA damage and it consists of a tran-
scriptional activation/repression domain followed by a basic
leucine zipper domain at its C-terminus [35]. Although it
was thought that CHOP functions as a negative regulator to
sequester binding partners [36], subsequent studies showed
that a CHOP-C/EBP heterodimer could bind DNA and func-
tion as a transcriptional activator [37–39]. It is proposed that
CHOP mediates induction of the apoptotic genes Gadd34, Dr5,
Bim and Trb3, and repression of antiapoptotic Bcl2 expression
[33,39,40].
Protein Misfolding in the ER and Oxidative
Stress
There is accumulating evidence to suggest that protein mis-
folding in the ER and production of reactive oxygen species
(ROS) are closely linked; however, this area of ER stress is
not well explored. In eukaryotes, oxidative protein folding
occurs in the ER. A growing family of ER oxidoreductases,
including protein disulphide isomerase (PDI), ERp57, ERp72,
PDIR, PDIp and P5, catalyse these protein-folding reactions in
mammalian cells. PDI catalyses the formation, isomerization
and reduction of disulphide bonds in vitro. When disulphide
bond formation occurs, cysteine residues within the PDI active
site [-C-X-X-C-] accept two electrons from thiol residues in
the polypeptide chain substrate. This electron transfer results
in the oxidation of the substrate and the reduction of the PDI
active site. It is now recognized that reduced PDI transfers its
electrons through ER oxidoreductase 1 (ERO1) to molecular
oxygen as the final electron acceptor [41].
During formation of disulphide bonds, hydrogen peroxide is
formed as a by-product from the sequential action of PDI and
ERO1 in transferring electrons from thiol groups in proteins
to molecular oxygen. It has been estimated that approximately
25% of the ROS generated in a cell may result from formation
of disulphide bonds in the ER during oxidative protein fold-
ing [41]. In addition, ROS may be formed as a consequence of
the glutathione (GSH) depletion that occurs as GSH reduces
unstable and improper disulphide bonds. The consumption
of GSH would return thiols involved in non-native disulphide
bonds to their reduced form so they may again interact with
ERO1/PDI to be reoxidized. This would generate a futile cycle
of disulphide bond formation and breakage in which each
cycle would generate ROS and consume GSH (figure 3). As
a consequence, it is expected that proteins that have multiple
disulphide bonds may be more prone to generating oxidative
stress. Our recent findings show that excessive protein syn-
thesis and unfolded protein accumulation in the ER lumen
can cause oxidative stress [42]. The ROS generated by these
processes appear to be a critical second signal to initiate apop-
tosis (figure 3). In addition, our findings suggest that ROS
can further disrupt protein misfolding in the ER. Intriguingly,
antioxidants can improve protein folding and reduce apoptosis
under conditions of ER stress.
UPR Induction of ATF4 and CHOP
and Apoptosis
How do cells decide between the fates of survival and death
in response to activation of the UPR? Our recent studies, as
well as others, indicate that CHOP is a crucial factor that
signals apoptosis [43]. Surprisingly, cells in which the UPR is
chronically activated at a low level can propagate indefinitely
because the stress from the initial insult is resolved. The res-
olution correlates with upregulation of ER chaperones and
ERAD machinery. Survival under these conditions is associ-
ated with attenuated expression of CHOP, and GADD34, a
downstream target of CHOP [43]. In the presence of perpet-
ual CHOP expression, cells succumb to apoptotic death. We
showed that the half-lives for mRNAs and proteins encoding
adaptive functions of the UPR (i.e. BiP, GRP94, p58IPK) are
long-lived, whereas those encoding apoptotic functions, ATF4,
CHOP and GADD34, are short-lived. Under adaptive condi-
tions, the steady-state levels of proteins that promote protein
folding and ERAD are increased, which feeds back to shut
off UPR signalling. In contrast, a perpetual strong misfolded
protein signal is required to activate the CHOP-mediated death
program. We have shown that Chop deletion improves both
β-cell survival and proinsulin secretion. Our studies suggest
that CHOP mediates apoptosis through induction of oxidative
stress. However, the relationship between signalling through
the PERK/eIF2α pathway to production of ROS is unknown. A
model was proposed that ATF4-mediated induction of CHOP
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Figure 3. Endoplasmic reticulum (ER) stress, protein misfolding and
oxidative stress are intimately interrelated. Protein folding within the
ER lumen is ushered by a family of oxidoreductases that catalyse
disulphide bond formation and isomerization. ER stress causes an
increase in the formation of incorrect intermolecular and/or intramolecular
disulphide bonds that require breakage and reformation for proteins to
attain the appropriate folded conformation. Protein disulphide isomerase
(PDI) catalyses disulphide bond formation and isomerization, whereas
glutathione transported into the ER reduces improperly paired disulphide
bonds. Reoxidation of PDI is mediated by ERO1; however, reactive oxygen
species (ROS) are produced in the process. Cellular ROS can deplete
glutathione and increase the misfolded protein load in the ER. In turn, ROS
can also cause ER stress through modification of proteins and lipids that are
necessary to maintain ER homeostasis. Consumption of excessive cellular
glutathione due to ER stress could inhibit glutaredoxin reduction and cause
accumulation of oxidized cytosolic proteins. ER stress also causes calcium
leak from the ER for accumulation in the inner mitochondrial matrix.
This calcium loading in the mitochondria can generate additional ROS
through disruption of electron transport and opening of the mitochondrial
permeability pore. Thus, accumulation of misfolded protein in the ER
increases ROS production that can further amplify ER stress, disrupt
insulin production and cause cell death.
causes transcriptional induction of GADD34 [31]. GADD34
encodes a regulatory subunit of protein phosphatase 1 (PP1)
that targets PP1 to dephosphorylate eIF2α, thereby reversing
the translational attenuation. We propose that under condi-
tions where protein folding is challenged, an increase in protein
synthesis would generate an increased amount of misfolded
protein (figure 4). Although the most significant pathway that
leads to CHOP induction is mediated through PERK, both the
IRE1/XBP1 and ATF6 pathways contribute.
UPR Activation in β-Cells Associated
with Type 2 Diabetes
If ER stress and UPR signalling are important for β-cell
function/survival, then (i) UPR gene induction should be
detectable in the islets of diabetic mice and human patients; (ii)
accumulation of unfolded protein in β-cells should cause β-cell
failure and diabetes and (iii) genetic deletion of critical UPR
signal transduction components should cause overwhelming
















Figure 4. β-Cells require exquisite regulation of protein synthesis by
eukaryotic initiation factor 2 α-subunit (eIF2α) phosphorylation. Our
studies have shown that protein kinase-like endoplasmic reticulum
kinase (PERK) activation initiates a cascade of events that include eIF2α
phosphorylation, increased ATF4 mRNA translation and transcriptional
activation of CHOP. Increased CHOP expression is associated with
oxidative stress. However, we have also shown that a defect in eIF2α
phosphorylation results in increased protein synthesis that also leads to
oxidative stress. We propose that increased CHOP expression induces
expression of GADD34 to direct protein phosphatase 1 (PP1)-mediated
dephosphorylation of eIF2α, thereby increasing protein synthesis. If protein
misfolding is not resolved, the increased cargo would further increase
misfolded protein accumulation, leading to reactive oxygen species (ROS).
The heavy black arrows depict the signalling pathway that occurs upon
eIF2α phosphorylation.
UPR Activation in Islets from Diabetic Mice and Men
Perhaps the most difficult test of UPR association with β-cell
failure is the detection of ER stress or defective ER stress sig-
nalling in islet samples from human patients. However, CHOP
nuclear localization was reported in pancreata of human obese
diabetic individuals, but it was rarely found in perinuclear or
nuclear localization in pancreata from control or type 1 dia-
betic patients [44]. The classical UPR-induced proteins p58IPK,
BiP and CHOP were significantly elevated in islets in tissue
sections from patients with type 2 diabetes [45]. Increased
levels of eIF2α phosphorylation, increased splicing of Xbp1
mRNA and increased CHOP and BiP protein were detected
in the islets of db/db mice, a common model of insulin resis-
tance and β-cell failure [45,46]. The detection of UPR-induced
signals in these samples does not prove that ER stress was a
causative event in the disease process; however, it does provide
the first evidence that UPR markers are elevated specifically in
the islets of diabetic men and mice. Further substantiating that
excessive ER stress or defective stress signalling are pathogenic
determinants of human diabetes will require more advanced
knowledge of the stimuli and function of the UPR in β-cells
and the development of sensitive methods to detect markers
of the UPR in human samples. One outstanding question is
whether insulin resistance causes an increase in proinsulin syn-
thesis that generates greater amounts of misfolded protein in
β-cells. The discovery of drugs that improve ER protein folding
and/or modulate ER stress signalling, which can be evaluated in
diabetic animal models and in human clinical trials, will greatly
advance our understanding of the importance of ER stress in
development and progression of diabetes.
102 Kaufman et al. Volume 12 No. (Suppl. 2) October 2010
DIABETES, OBESITY AND METABOLISM review article
β-Cell Failure: Mutant Proinsulin
Studies of Akita and Munich mice show that mutations at
cysteine residues that interfere with proper disulphide bond
formation within proinsulin induce ER stress and severe β-cell
destruction [47,48]. Deletion of the UPR-induced proapoptotic
gene Chop delayed onset of hyperglycaemia and β-cell failure
in the Akita mouse [48]. Human proinsulin with the analo-
gous Akita C96Y mutation was analysed and compared with
wild-type proinsulin through the development of expression
constructs that fuse green fluorescence protein (GFP) with the
C-peptide [49]. In these studies, it was possible to elucidate that
processing of hProC96YCpepGFP to insulin was completely
impaired in rat insulinoma-1 (INS-1) cells and expression
was ‘proteotoxic’ in comparison to control hProCpepGFP. In
humans, neonatal dominantly inherited diabetes in 16 families
was associated with missense mutations in the Ins gene [50].
The mutations are predicted to impair proinsulin disulphide
bond formation and activate ER stress. The missense mutations
affect residues directly involved in disulphide bond formation,
crucial residues adjacent to disulphide bridges, and also intro-
duce new cysteine residues that could interfere with correct
pairing of cysteine residues as nascent proinsulin molecules
undergo oxidative folding. Thus, disruption of disulphide bond
pairing in proinsulin, a crucial determinant of secondary struc-
ture and protein folding, is sufficient to induce diabetes in both
humans and mice.
β-Cell Failure: Deletion of ER Co-chaperone p58IPK
p58IPK was first described as an inhibitor of the double-
stranded RNA-activated eIF2α protein kinase R (PKR). It was
subsequently shown to inhibit activation of the eIF2α kinase
PERK [51,52]. The subcellular localization and function of this
protein has been a subject of debate; however, recent evidence
supports the notion that the majority of p58IPK is imported
into the ER lumen [53]. p58IPK is a member of the DnaJ co-
chaperone family that functions to stimulate the ATPase activity
of members of the Hsp70 family. Therefore, it was proposed
that p58IPK may act in the ER lumen as a co-chaperone for the
Hsp70 family member BiP [53]. Mice with null mutation of
p58IPK develop spontaneous diabetes because of destruction of
the islet mass, and p58IPK null mutation worsens the outcome
of diabetes due to the Akita Ins2 C96Y mutation [54,55]. These
intriguing findings merit further study on the role of p58IPK co-
chaperone function in proinsulin folding and maturation and in
diabetes. The observations suggest that there may be a number
of protein-folding chaperones that play highly significant roles
in preservation of ER function in the β-cell to prevent diabetes.
β-Cell Failure: Wolfram Syndrome and ER Dysfunction
Wolfram syndrome is a rare autosomal-recessive neurodegen-
erative disorder that is characterized by juvenile-onset diabetes
mellitus, optic atrophy and hearing impairment [56]. This syn-
drome is caused by loss-of-function mutations in the Wfs1
gene that encodes the protein wolframin [57,58]. Although
WFS1 is not a direct sensor of the UPR, analysis of Wfs1−/−
mice indicates that WFS1 function is closely linked with ER
homeostasis. Wfs1 null mutation reduces intracellular calcium
signalling upon glucose stimulation, induces UPR-regulated
genes and disrupts cell cycle control, leading to apopto-
sis [59–61]. Recently, a physical interaction between WFS1
and the Na(+)/K(+)ATPase β1 subunit was discovered, and
it was discerned that WFS1 was required for trafficking of the
subunit to the cell surface. Reduced levels of this ATPase sub-
unit were detected in the plasma membrane fraction of Wfs1
mutant fibroblasts and of Wfs1 knockdown MIN6 β-cells [62].
Wolframin may serve a general function to assist in the assem-
bly of subunits of oligomeric proteins before exit from the
ER. Consistent with these observations, loss of function in the
chaperone WFS1 causes ER stress and β-cell failure.
β-Cell Failure: Mutations in PERK/eIF2α
Wolcott-Rallison syndrome was first reported in the early
1970s as a human disease characterized by infantile diabetes,
multiple epiphyseal dysplasia and growth retardation [63,64].
Pancreas atrophy and endocrine and exocrine insufficiency
were observed [65,66]. Wolcott-Rallison syndrome has been
associated with multiple other pathologies including osteope-
nia, hepatic and renal complications, cardiovascular disease and
mental retardation. Remarkably, it was learned nearly 30 years
later that this syndrome results from loss of protein kinase func-
tion mutations in the eIF2α kinase PERK (EIF2AK3) [67,68].
Furthermore, polymorphisms at the PERK locus were linked
to type 1 diabetes in South Indian populations [69].
Perk deletion in the mouse recapitulates many of the defects
of the human syndrome including diabetes due to degener-
ation of β-cell mass after birth and failure of the exocrine
pancreas [70,71]. In these studies, ER distention, a character-
istic of ER dysfunction, was observed in pancreatic β-cells. In
addition, the rate of glucose-stimulated proinsulin synthesis
was enhanced, consistent with a defect in the ability to properly
attenuate proinsulin mRNA translation. The findings suggested
that the β-cells of these mice were susceptible to ER overload
and unresolved ER stress leading to apoptosis. Conditional
deletion of Perk at varying times in development suggested
that the development of β-cell mass, but not maintenance of a
population of adult β-cells, is dependent upon this kinase [72].
It is possible that one or more additional eIF2α kinases, general
amino acid control 2 (GCN2), heme-regulated inhibitor (HRI)
or ds-RNA-activated protein kinase (PKR), are capable of sup-
porting the minimal requirement for eIF2α phosphorylation
and translational control in response to in vivo stimuli.
Concurrent with studies on Perk null mice, mice that harbour
a homozygous knock-in mutation at the PERK phosphoryla-
tion site in eIF2α (Ser51Ala) were shown to have defects in
embryonic β-cell survival, liver glycogen storage, postnatal
induction of gluconeogenesis, inhibition of translation under
conditions of ER stress and transcriptional induction of UPR
genes [17]. The Ser51Ala eIF2α mutation prevents any compen-
satory phosphorylation because of activation of other eIF2α
kinases and therefore, very effectively blocks stress-induced
translation attenuation and ATF4-dependent transcriptional
induction. Mice with homozygous Ser51Ala eIF2α mutation die
from postnatal hypoglycaemia. This observation was the first
indication that the UPR has a broader role than maintaining
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functional ER protein folding, but is also intimately connected
with metabolic homeostasis [17]. It is now known that all UPR
signalling pathways contribute to glucose and lipid home-
ostasis [22,73,74]. Because the homozygous Ser51Ala eIF2α
mutation was a neonatal lethal phenotype with a severe β-cell
deficiency, further studies were performed by analysis of β-cell
function in heterozygous Ser51Ala eIF2α mice [75]. The het-
erozygous animals did not spontaneously manifestβ-cell failure
because of reduced ER stress signalling. However, upon feed-
ing a 45% high-fat diet, these mice developed elevated fasting
blood glucose, glucose intolerance and a β-cell secretion defect.
It was shown that the insulin secretion defect was because of
an increased rate of glucose-stimulated translation that over-
whelmed the protein folding machinery of the ER and led to
(i) distention of the ER compartment, (ii) prolonged associa-
tion of misfolded proinsulin with the ER chaperone BiP and
(iii) reduced secretory granule content. Thus, the regulation
of translational initiation through eIF2α phosphorylation is
required for ER stress signalling to prevent β-cell dysfunction,
when insulin demand is increased because of a high-fat diet
and insulin resistance. These findings showed that translational
control through eIF2α phosphorylation is essential to maintain
the functional integrity of the ER.
As ER distention and β-cell death in homozygous Ser51Ala
eIF2α islets were apparent embryonically in the absence of any
exogenous pressure to drive β-cell failure, it is likely that there
are physiological stimuli that cause eIF2α phosphorylation
early in development that is crucial for β-cell survival [17]. It
is unlikely that the β-cell requirement for eIF2α phosphoryla-
tion is mediated through increased translation of Atf4 mRNA,
because Atf4−/− mice do not display β-cell defects [76]. How-
ever, the embryonic β-cell apoptosis observed in homozygous
Ser51Ala eIF2α mice was likely, at least in part, signalled through
CHOP. Although disruption of the Chop gene did not rescue the
postnatal hypoglycaemia-induced lethality of Ser51Ala eIF2α
mice, the β-cells in islets from E18.5 Ser51Ala eIF2α;Chop−/−
mice were significantly increased in number and insulin con-
tent, and displayed reduced apoptosis compared with islets
from Ser51Ala eIF2α;Chop+/+ mice [77]. These findings sup-
port the hypothesis that a significant portion of the β-cell
apoptosis in Ser51Ala eIF2α mutant mice is caused by CHOP,
and that CHOP induction is not solely dependent on eIF2α
phosphorylation. However, importantly, these findings show
that CHOP is not the only pathway leading to β-cell death
in the absence of eIF2α phosphorylation. In the absence of
CHOP, other death pathways involving both mitochondrial-
dependent and -independent pathways are invoked. The sum of
these findings indicates that genetic defects in the PERK/eIF2α
signal transduction pathway are sufficient to disrupt regulated
mRNA translation and interfere with ER function in the β-cell,
thereby causing reduced insulin secretion, β-cell death and
diabetes in mice and humans.
The Role of Protein Misfolding and
Oxidative Stress in β-Cell Failure
To determine whether CHOP contributes to the β-cell failure
associated with type 2 diabetes, we analysed the effect of Chop
deletion in three different models of murine type 2 diabetes:
(i) heterozygous Ser51Ala eIF2α mutant mice fed a high-fat
diet; (ii) high-fat diet and streptozotocin (STZ)-treated mice
and (iii) db/db leptin receptor-null mice [77]. In all models,
Chop deletion increased β-cell mass, improved β-cell function,
reduced β-cell apoptosis and prevented glucose intolerance.
Surprisingly, Chop deletion not only reduced apoptosis but also
preserved β-cell function, as monitored by the integrity of the
secretory pathway, insulin expression and glucose-stimulated
insulin secretion. Analysis of gene expression suggested that
Chop deletion may improve the capacity of the β-cell to tolerate
oxidative stress. Indeed, islets from Chop−/− mice displayed
no significant difference in oxidative damage compared with
wild-type mice. However, upon incubation in the presence
of tunicamycin to inhibit N-linked glycosylation and cause
misfolded protein accumulation in the ER, there was a sig-
nificant increase in protein oxidation and lipid peroxidation
in wild-type islets, where the damage was significantly attenu-
ated in Chop−/− islets [77]. In contrast, upon treatment with
the oxidant H2O2, similar amounts of oxidative damage were
detected in islets from both strains of mice. Therefore, Chop
deletion reduced the oxidative damage that occurs in response
to protein misfolding in the ER, but not in response to gen-
eral oxidative stress. We conclude that Chop deletion not only
promoted islet hyperplasia but surprisingly also improved the
function of the β-cells to maintain insulin production, possibly
through reduction of oxidative stress.
eIF2α Phosphorylation Prevents Oxidative
Stress in β-Cells
To elucidate why eIF2α phosphorylation is required to pre-
serve β-cell function, we generated mice with conditional
homozygous Ser51Ala eIF2α mutation in β-cells. Ubiquitous
transgenic expression of wild-type eIF2α cDNA rescued the
postnatal lethality associated with the homozygous Ser51Ala
eIF2α mutation. The rescued mice were viable, fertile and
displayed normal glucose tolerance and homeostasis. Locus
of X-over P1 (LoxP) sites flanked the wild-type eIF2α cDNA
within the transgene so that when deleted, GFP was expressed.
Upon breeding these mice to transgenic mice harbouring the
rat insulin II promoter tamoxifen (Tam)-regulated Cre recom-
binase [78], the wild-type eIF2α cDNA was efficiently deleted
in more than 90% of the β-cells. Three weeks after administra-
tion of Tam, nearly all of the β-cells had deleted the wild-type
eIF2α cDNA, although there was no significant change in islet
mass or insulin content and the mice were glucose intoler-
ant [76]. At 3 weeks after Tam injection, there were terminal
deoxynucleotidyl transferase mediated dUTP nick end labeling
essay (TUNEL)-positive β-cells, prior to the onset of detectable
hyperglycaemia, suggesting that β-cell failure and apoptosis
were not a consequence of lipid or glucose toxicity [76] . In
addition, ultrastructural analysis identified significantly dis-
tended ER and swollen mitochondria in β-cells at 3 weeks
after deletion of the transgene. Finally, oxidative damage was
detected co-incident with the appearance of TUNEL-positive
β-cells, suggesting that blockade of ER stress signalling by pre-
venting eIF2α phosphorylation overloads the ER compartment
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causing accumulation of unfolded protein, oxidative stress and
subsequent irreversible commitment to cell death.
We explored the causal relationship between ROS and
disruption of glucose homeostasis in this in vivo mouse model
of diabetes due to translation-induced overload. We found that
diet supplemented with antioxidant butylated hydroxyanisole
(BHA) could reduce β-cell apoptosis, increase insulin content
and improve glucose homeostasis in mice with homozygous
Ser51Ala eIF2α mutation in β-cells [76]. These findings suggest
that reducing ROS in β-cells deficient in eIF2α phosphorylation
could improve their function and that ROS may be a cause for
the β-cell failure and apoptosis.
The Role of IRE1α and ATF6α UPR Signalling
in β-Cells
A fundamental question regarding β-cell function and survival
is which UPR subpathways are required for β-cell function
and what elements of these responses are protective or detri-
mental to β-cell survival upon acute or unresolved ER stress.
We have recently shown that β-cell-specific deletion of Ire1α
causes hyperglycaemia because of β-cell failure (unpublished).
Therefore, signalling through IRE1α is apparently also required
to preserve β-cell function. In contrast, mice with homozygous
deletion of Atf6α displayed normal glucose homeostasis on a
standard chow diet. Future studies should investigate whether
high-fat diet may uncover a requirement for ATF6α for β-cell
compensation when challenged with insulin resistance. Evi-
dence that defects in the IRE1α and ATF6α subpathways of
the UPR are akin to null mutation of PERK in causing human
diabetes has yet to be presented. However, further analysis of
mouse models with UPR gene deletions should solidify the
concept that the UPR sensors act in concert with each pathway,
supporting a unique and indispensable role in preservation of
β-cell function and/or survival.
Conclusion
Our results show that the absence of eIF2α phosphorylation,
as well as excessive eIF2α phosphorylation (through CHOP
induction), leads to oxidative stress. We propose that both
events lead to increases in protein synthesis that contributes
to the oxidative stress (figure 4). Presently, most data support
the idea that CHOP is induced by the PERK/eIF2α/ATF4 as
well as the IRE1/XBP1 and ATF6 UPR subpathways to activate
proapoptotic gene expression, restore translation initiation and
increase the oxidizing potential in the ER lumen [31,79]. CHOP
induces expression of GADD34, a subunit of type 1 protein
phosphatase that directs eIF2α dephosphorylation to increase
mRNA translation as homeostasis in the ER is restored [ 31,80].
CHOP is also implicated in the induction of ERO1α, a molecule
that oxidizes PDI so it can function to rearrange improperly
formed disulphide bonds within unfolded proteins. Disulphide
bond formation during oxidative protein folding in the ER
generates oxidative stress as a consequence of electron transfer
from cysteine residues through PDI and ERO1 to molecular
oxygen to form hydrogen peroxide [41]. Future studies should
elucidate whether Chop deletion protects β-cells from oxidative
damage through the reduced expression of GADD34 and/or
ERO1.
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